APA

Bohula E. A., Aylward P. E., Bonaca M. P., Corbalan R. L., Kiss R. G., Murphy S. A., Scirica B. M., White H., Braunwald E. & Morrow D. A. (20160229). Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50. : Circulation.

Chicago

Bohula Erin A, Aylward Philip E, Bonaca Marc P, Corbalan Ramon L, Kiss Robert G, Murphy Sabina A, Scirica Benjamin M, White Harvey, Braunwald Eugene and Morrow David A. 20160229. Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50. : Circulation.

Harvard

Bohula E. A., Aylward P. E., Bonaca M. P., Corbalan R. L., Kiss R. G., Murphy S. A., Scirica B. M., White H., Braunwald E. and Morrow D. A. (20160229). Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50. : Circulation.

MLA

Bohula Erin A, Aylward Philip E, Bonaca Marc P, Corbalan Ramon L, Kiss Robert G, Murphy Sabina A, Scirica Benjamin M, White Harvey, Braunwald Eugene and Morrow David A. Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50. : Circulation. 20160229.